Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Production / Operations

Glass House Brands Announces Accelerated 2026 Expansion Strategy

By The Northwire Desk — AI Analysis Jan 20, 2026 · 07:30 GLAS · 8.69 None
GLAS · Price

Executive Summary

  • Glass House Brands Inc. announced an accelerated expansion plan to bring two additional greenhouses online in 2026, adding roughly 300,000 lb of annual biomass capacity.
  • The company completed the first third of Greenhouse 2 (its fourth greenhouse) and will begin planting there in Q1 2026, with full build‑out targeted for Q2 2026.
  • A light‑retrofit and build‑out of Greenhouse 4 has begun to support future international CBD and hemp export opportunities and a reimbursable CBD market anticipated under forthcoming federal reforms.

Key Details

  • Greenhouse 2:
  • First third completed; full planting expected in Q1 2026, with complete build‑out by Q2 2026.
  • Incremental annual production capacity ≈ 300,000 lb of biomass.
  • Greenhouse 4:
  • Light retrofit and construction underway to enable production for international CBD/hemp markets.
  • Operational Status:
  • Returned to full production capacity in existing greenhouses prior to year‑end 2025 after a temporary step‑back.
  • Ended 2025 with the highest planted acreage in company history; contributions from Greenhouse 2 will appear in Q1 2026 results.
  • Strategic Outlook:
  • Expansion driven by positive results from earlier development phases and anticipated cannabis reform actions (e.g., potential Schedule III rescheduling, Medicare‑reimbursable CBD program).
  • Management expects higher wholesale biomass prices outside California and plans to become a supplier for the emerging reimbursable CBD market.
  • Leadership Comments:
  • Kyle Kazan, Co‑Founder, Chairman & CEO, expressed confidence in ramp‑up efforts and strong growth expectations for 2026 and beyond.

Notable Quotes

“We are very pleased with and proud of our team’s ramp back efforts of the past six months for existing greenhouses along with early results from Greenhouse 2 expansion. The Company is ready to put its foot fully back on the gas pedal. We anticipate strong growth in 2026 and beyond.” – Kyle Kazan, Co‑Founder, Chairman & CEO

“We excitedly await the final execution of President Trump’s executive order… We are planning for the associated new business opportunities that we expect to come from cannabis rescheduling and the creation of the new Medicare reimbursement program for CBD.” – Kyle Kazan

Read the original news release →

More from None

Apr 13, 2026 · 17:34

Vireo Growth, Glass House enter California JV

M&A / Property Jan 20, 2026 · 17:20

Glass House talks 2026 expansion plans

Production / Operations Jan 13, 2026 · 07:30

University of California Berkeley and Glass House Collaboration Leads to State-Funded Research on Cannabis Crop Yields

M&A / Property Dec 19, 2025 · 15:04

Glass House applauds U.S. cannabis reform action

Regulatory Dec 19, 2025 · 08:00

Glass House Brands Applauds Cannabis Reform Action

Regulatory Nov 12, 2025 · 16:05

Glass House Brands Reports Third Quarter 2025 Financial Results

Earnings